Hariri Robert J 4

What Happened

• Robert J. Hariri, Celularity Inc. CEO, had restricted stock units (RSUs) vest on April 13, 2026. Upon vesting, 3,281 RSUs converted into Class A common shares (reported as a conversion/exercise of a derivative at $0.00 per share).
• To cover tax withholding on the vesting event, 1,182 shares were surrendered/withheld (disposition) at a reported value of $1.28 per share, totaling $1,513. This was not an open-market sale tied to investment sentiment but a routine tax-withholding on vested awards.

Key Details

• Transaction date: April 13, 2026; Form 4 filed April 15, 2026 (timely filing).
• Conversion: 3,281 RSUs converted into shares at $0.00 (RSU vesting/conversion).
• Tax withholding: 1,182 shares withheld/disposed at $1.28/share for $1,513 total.
• Footnotes: RSUs were originally granted on April 13, 2022 (13,123 RSUs total; 25% vested on April 13, 2026). Each RSU equals one share. The vested shares converted are reported in Table I of the Form 4.
• Shares owned after the transaction: reported in Table I of the Form 4 (not included in the excerpt provided).

Context

• This was an RSU vesting event (award conversion), not a voluntary market purchase or strategic sale. The withheld shares reflect tax obligations rather than a signal of buying or selling intent.
• For retail investors: RSU vesting is common executive compensation; the tax-withholding portion is routine and should not be interpreted as a directional insider trade.